Influence of immunosuppression on patient survival after liver transplantation for hepatitis C.
Mueller
A R
AR
Department of Surgery, Virchow Clinic, Humboldt University of Berlin, Berlin, Germany.
Platz
K
K
Willimski
C
C
Berg
T
T
Steinmüller
T
T
Neumann
U
U
Neuhaus
R
R
Hopf
U
U
Radke
C
C
Neuhaus
P
P
D016572:Cyclosporine / Q000009:adverse effects; D006084:Graft Rejection / Q000401:mortality / Q000517:prevention & control; D016174:Hepacivirus / Q000502:physiology; D006526:Hepatitis C / Q000401:mortality* / Q000601:surgery / Q000821:virology; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects; D016031:Liver Transplantation / Q000276:immunology / Q000401:mortality*; D015999:Multivariate Analysis; D012008:Recurrence; D016019:Survival Analysis; D016559:Tacrolimus / Q000009:adverse effects; D014779:Virus Replication
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus